Brd4 Regulates the Homeostasis of CD8+ T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation

Zhilin Peng,Yiwen Zhang,Xiancai Ma,Mo Zhou,Shiyu Wu,Zheng Song,Yaochang Yuan,Yingshi Chen,Yuzhuang Li,Guanwen Wang,Feng Huang,Yidan Qiao,Baijing Xia,Weiwei Liu,Jun Liu,Xu Zhang,Xin He,Ting Pan,Hanshi Xu,Hui Zhang

DOI: https://doi.org/10.3389/fimmu.2021.728082

IF: 7.3

2021-08-26

Frontiers in Immunology

Abstract:CD8 + T cells are major components of adaptive immunity and confer robust protective cellular immunity, which requires adequate T-cell numbers, targeted migration, and efficient T-cell proliferation. Altered CD8 + T-cell homeostasis and impaired proliferation result in dysfunctional immune response to infection or tumorigenesis. However, intrinsic factors controlling CD8 + T-cell homeostasis and immunity remain largely elusive. Here, we demonstrate the prominent role of Brd4 on CD8 + T cell homeostasis and immune response. By upregulating Myc and GLUT1 expression, Brd4 facilitates glucose uptake and energy production in mitochondria, subsequently supporting naïve CD8 + T-cell survival. Besides, Brd4 promotes the trafficking of naïve CD8 + T cells partially through maintaining the expression of homing receptors (CD62L and LFA-1). Furthermore, Brd4 is required for CD8 + T cell response to antigen stimulation, as Brd4 deficiency leads to a severe defect in clonal expansion and terminal differentiation by decreasing glycolysis. Importantly, as JQ1, a pan-BRD inhibitor, severely dampens CD8 + T-cell immune response, its usage as an anti-tumor agent or latency-reversing agent for human immunodeficiency virus type I (HIV-1) should be more cautious. Collectively, our study identifies a previously-unexpected role of Brd4 in the metabolic regulation of CD8 + T cell-mediated immune surveillance and also provides a potential immunomodulation target.

immunology